Table 2 Pairwise comparisons between the intranasal dexmedetomidine and intranasal esketamine groups
Variable | Levels | Intranasal dexmedetomidine N 15 | Intranasal esketamine N 14 | P-value | Missing |
|---|---|---|---|---|---|
Higghest FLACC | 1 (0–3) | 5 (2–6.75) | 0.09 | ||
Highest Ramsay | 3 (2–3) | 2 (1–2) | 0.02 | ||
ED Phycisian grading | 1 = Very easy | 8 (57.1%) | 3 (21.4%) | 0.21 | 1 IN DEX |
2 = Easy | 4 (28.6%) | 6 (42.8%) | |||
3 = Not easy—not difficult | 2 (14.3%) | 2 (14.3%) | |||
4 = Difficult | 0 | 2 (14.3%) | |||
5 = Very difficult | 0 | 1 (7.1%) | |||
Parental satisfaction | 1 = Not satisfied | 0 | 1 (7.7%) | 0.10 | 2 IN DEX |
2 = Somewhat satisfied | 0 | 0 | |||
3 = Neutral | 0 | 1 (7.7%) | |||
4 = Satisfied | 2 (14.3%) | 5 (38.4%) | |||
5 = Very satisfied | 12 (85.7%) | 6 (46.2%) | |||
Pain assessed by parents (FPS-R) | 2 (0–5) | 5 (0–8) | 0.44 | 2 IN DEX |